Is angiogenesis an organizing principle in biology and medicine?
Folkman
Judah
J
Children's Hospital Boston, Department of Surgery and Vascular Biology Program, Harvard Medical School, Karp Family Research Laboratories 12.129, Boston, MA 02115-5737, USA. judah.folkman@childrens.harvard.edu
D043925:Angiogenesis Inducing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D001681:Biological Assay; D001792:Blood Platelets / Q000502:physiology; D002642:Chick Embryo; D003692:Delayed-Action Preparations; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy / Q000503:physiopathology; D051379:Mice; D009369:Neoplasms / Q000098:blood supply* / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology; D020543:Proteome / Q000502:physiology; D011817:Rabbits
D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors; D003692:Delayed-Action Preparations; D020543:Proteome; D016222:Fibroblast Growth Factor 2